LX
Lexeo Therapeutics, Inc. Common Stock (LXEO)
NASDAQ·Healthcare·Biotechnology
$5.77
+2.58%
Mkt Cap $433.41M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 30, 2026 | — | — | — | -$0.32 | -$0.27 | +15.62% | — | — |
| Q4 2025 Nov 5, 2025 | — | — | — | -$0.48 | -$0.33 | +31.25% | — | — |
| Q3 2025 Aug 14, 2025 | — | — | — | -$0.64 | -$0.60 | +6.25% | — | — |
| Q2 2025 May 12, 2025 | — | — | — | -$0.80 | -$0.99 | -23.75% | — | — |
| Q1 2025 Mar 24, 2025 | — | — | — | -$0.87 | -$0.78 | +10.34% | — | — |
| Q4 2024 Nov 13, 2024 | — | — | — | -$0.65 | -$0.89 | -36.92% | — | — |
| Q3 2024 Aug 12, 2024 | — | — | — | -$0.69 | -$0.64 | +7.25% | — | — |
| Q2 2024 May 9, 2024 | — | — | — | -$0.76 | -$0.77 | -1.32% | — | — |
| Q1 2024 Mar 11, 2024 | — | — | — | -$0.73 | -$0.85 | -16.44% | — | — |
| Q4 2023 Nov 6, 2023 | — | — | — | -$2.60 | -$12.36 | -375.38% | — | — |
| Q2 2023 Jun 30, 2023 | — | — | — | — | -$0.53 | — | — | — |
| Q1 2023 Mar 31, 2023 | — | — | — | — | -$0.74 | — | — | — |
| Q4 2022 Dec 31, 2022 | — | $654.00K | — | — | -$0.59 | — | — | — |
| Q3 2022 Sep 30, 2022 | — | $531.00K | — | — | -$0.68 | — | — | — |
| Q2 2022 Jun 30, 2022 | — | $37.00K | — | — | -$0.60 | — | — | — |
| Q1 2022 Mar 30, 2022 | — | $85.55K | — | — | -$0.47 | — | — | — |